{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:31:43Z","timestamp":1787592703302,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004006","name":"bilimsel ara\u015ftirma projeleri birimi, istanbul \u00fcniversitesi","doi-asserted-by":"publisher","award":["32550"],"award-info":[{"award-number":["32550"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12032-021-01577-9","type":"journal-article","created":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T06:02:42Z","timestamp":1634968962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The apoptotic efficacy of succinic acid on renal cancer cell lines"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9766-4361","authenticated-orcid":false,"given":"Goksu","family":"Kasarci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3878-1829","authenticated-orcid":false,"given":"Baris","family":"Ertugrul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3465-1808","authenticated-orcid":false,"given":"Elif Sinem","family":"Iplik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7960-9131","authenticated-orcid":false,"given":"Bedia","family":"Cakmakoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,23]]},"reference":[{"issue":"1\u20136","key":"1577_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/CBM-2011-0176","volume":"9","author":"P Cairns","year":"2011","unstructured":"Cairns P. Renal cell carcinoma. Cancer Biomark. 2011;9(1\u20136):461\u201373. https:\/\/doi.org\/10.3233\/CBM-2011-0176.","journal-title":"Cancer Biomark"},{"issue":"3","key":"1577_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"1577_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00345-018-2286-7","volume":"36","author":"SH Rossi","year":"2018","unstructured":"Rossi SH, Klatte T, Usher-Smith J, Stewart GD. Epidemiology and screening for renal cancer. World J Urol. 2018;36(9):1341\u201353. https:\/\/doi.org\/10.1007\/s00345-018-2286-7.","journal-title":"World J Urol"},{"issue":"1","key":"1577_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93\u2013105. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.029.","journal-title":"Eur Urol"},{"issue":"10","key":"1577_CR5","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/ijms18102195","volume":"18","author":"K Inamura","year":"2017","unstructured":"Inamura K. Renal cell tumors: understanding their molecular pathological epidemiology and the 2016 WHO classification. Int J Mol Sci. 2017;18(10):2195. https:\/\/doi.org\/10.3390\/ijms18102195.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1577_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s12291-017-0713-y","volume":"33","author":"A Kumar","year":"2017","unstructured":"Kumar A, Kumari N, Gupta V, Prasad R. Renal cell carcinoma: molecular aspects. Indian J Clin Biochem. 2017;33(3):246\u201354. https:\/\/doi.org\/10.1007\/s12291-017-0713-y.","journal-title":"Indian J Clin Biochem"},{"issue":"6","key":"1577_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.mpdhp.2018.05.001","volume":"24","author":"M Bonert","year":"2018","unstructured":"Bonert M, El-Shinnawy I. Subtypes of renal cell carcinoma with defined genomic alterations: diagnostic and prognostic significance. Diagn Histopathol. 2018;24(6):191\u20137. https:\/\/doi.org\/10.1016\/j.mpdhp.2018.05.001.","journal-title":"Diagn Histopathol"},{"issue":"6","key":"1577_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00261-016-0692-0","volume":"41","author":"NR Dunnick","year":"2016","unstructured":"Dunnick NR. Renal cell carcinoma: staging and surveillance. Abdom Radiol. 2016;41(6):1079\u201385. https:\/\/doi.org\/10.1007\/s00261-016-0692-0.","journal-title":"Abdom Radiol."},{"issue":"3","key":"1577_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/bbb.1327","volume":"6","author":"K-K Cheng","year":"2012","unstructured":"Cheng K-K, Zhao X-B, Zeng J, Zhang JA. Biotechnological production of succinic acid: current state and perspectives. Biofuels Bioprod Biorefin. 2012;6(3):302\u201318. https:\/\/doi.org\/10.1002\/bbb.1327.","journal-title":"Biofuels Bioprod Biorefin"},{"key":"1577_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s002530051431","volume":"51","author":"JG Zeikus","year":"1999","unstructured":"Zeikus JG, Jain MK, Elankovan P. Biotechnology of succinic acid production and markets for derived industrial products. Appl Microbiol Biotechnol. 1999;51:545\u201352. https:\/\/doi.org\/10.1007\/s002530051431.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6988","key":"1577_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nature02488","volume":"429","author":"W He","year":"2004","unstructured":"He W, Miao FJP, Lin DCH, Schwandner RT, Wang Z, Gao J, Chen JL, Tlan H, Ling L. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature. 2004;429(6988):188\u201393. https:\/\/doi.org\/10.1038\/nature02488.","journal-title":"Nature"},{"issue":"1","key":"1577_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-014-0078-2","volume":"12","author":"CJ Aguiar","year":"2014","unstructured":"Aguiar CJ, Rocha-Franco JA, Sousa PA, Santos AK, Ladeira M, Rocha-Resende C, Ladeira LO, Resende RR, Botoni FA, Melo MB, et al. Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation. Cell Commun Signal. 2014;12(1):1\u201317. https:\/\/doi.org\/10.1186\/s12964-014-0078-2.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"1577_CR13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/ki.2009.360","volume":"76","author":"JH Robben","year":"2009","unstructured":"Robben JH, Fenton RA, Vargas SL, Schweer H, Peti-Peterdi J, Deen PMT, Milligan G. Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int. 2009;76(12):1258\u201367. https:\/\/doi.org\/10.1038\/ki.2009.360.","journal-title":"Kidney Int"},{"issue":"11","key":"1577_CR14","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.amjhyper.2007.05.010","volume":"20","author":"N Sadagopan","year":"2007","unstructured":"Sadagopan N, Li W, Roberds SL, Major T, Preston GM, Yu Y, Tones MA. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am J Hypertens. 2007;20(11):1209\u201315. https:\/\/doi.org\/10.1016\/j.amjhyper.2007.05.010.","journal-title":"Am J Hypertens"},{"issue":"1","key":"1577_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ceca.2009.11.003","volume":"47","author":"CJ Aguiar","year":"2010","unstructured":"Aguiar CJ, Andrade VL, Gomes ERM, Alves MNM, Ladeira MS, Pinheiro ACN, Gomes DA, Almeida AP, Goes AM, Resende RR, et al. Succinate modulates Ca2+ transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium. 2010;47(1):37\u201346. https:\/\/doi.org\/10.1016\/j.ceca.2009.11.003.","journal-title":"Cell Calcium"},{"issue":"10","key":"1577_CR16","doi-asserted-by":"publisher","first-page":"13091","DOI":"10.1096\/fj.202001037R","volume":"34","author":"X Li","year":"2020","unstructured":"Li X, Xie L, Qu X, Zhao B, Fu W, Wu B, Wu J. GPR91, a critical signaling mechanism in modulating pathophysiologic processes in chronic illnesses. FASEB J. 2020;34(10):13091\u2013105. https:\/\/doi.org\/10.1096\/fj.202001037R.","journal-title":"FASEB J"},{"key":"1577_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.14715\/cmb\/2018.64.1.11","volume":"64","author":"ES Iplik","year":"2018","unstructured":"Iplik ES, Catmakas T, Cakmakoglu B. A new target for the treatment of endometrium cancer by succinic acid. Cell Mol Biol (Noisy-le-grand). 2018;64:60\u20133. https:\/\/doi.org\/10.14715\/cmb\/2018.64.1.11.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"1577_CR18","doi-asserted-by":"publisher","first-page":"31172","DOI":"10.1016\/j.arcmed.2020.10.022","volume":"20","author":"B Ertugrul","year":"2020","unstructured":"Ertugrul B, Iplik ES, Cakmakoglu B. In vitro inhibitory effect of succinic acid on T-cell acute lymphoblastic leukemia cell lines. Arch Med Res. 2020;20(1):31172\u20133. https:\/\/doi.org\/10.1016\/j.arcmed.2020.10.022.","journal-title":"Arch Med Res"},{"key":"1577_CR19","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3892\/or.2019.6958","volume":"41","author":"CW Wei","year":"2019","unstructured":"Wei CW, Yu YL, Chen YH, Hung YT, Yiang GT. Anticancer effects of methotrexate in combination with \u03b1-tocopherol and \u03b1-tocopherol succinate on triple-negative breast cancer. Oncol Rep. 2019;41:2060\u20136. https:\/\/doi.org\/10.3892\/or.2019.6958.","journal-title":"Oncol Rep"},{"issue":"10","key":"1577_CR20","first-page":"2483","volume":"63","author":"W Yu","year":"2003","unstructured":"Yu W, Sanders BG, Kline K. RRR-\u03b1-tocopheryl succinate-induced apoptosis of human breast cancer cells involves bax translocation to mitochondrial. Cancer Res. 2003;63(10):2483\u201391.","journal-title":"Cancer Res"},{"issue":"1","key":"1577_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1021\/np030293k","volume":"67","author":"N Nakamura","year":"2004","unstructured":"Nakamura N, Hirakawa A, Gao JJ, Kakuda H, Shiro M, et al. Five new maleic and succinic acid derivatives from the mycelium of Antrodia camphorata and their cytotoxic effects on LLC tumor cell line. J Nat Prod. 2004;67(1):46\u20138. https:\/\/doi.org\/10.1021\/np030293k.","journal-title":"J Nat Prod"},{"issue":"3","key":"1577_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/biom8030097","volume":"8","author":"C S\u00e1nchez-Rodr\u00edguez","year":"2018","unstructured":"S\u00e1nchez-Rodr\u00edguez C, Palao-Suay R, Rodrig\u00e1\u00f1ez L, et al. \u03b1-Tocopheryl succinate-based polymeric nanoparticles for the treatment of head and neck squamous cell carcinoma. Biomolecules. 2018;8(3):97. https:\/\/doi.org\/10.3390\/biom8030097.","journal-title":"Biomolecules"},{"issue":"1","key":"1577_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/pharmaceutics10010032","volume":"10","author":"SM Hossain","year":"2018","unstructured":"Hossain SM, Chowdhury EH. Citrate- and succinate-modified carbonate apatite nanoparticles with loaded doxorubicin exhibit potent anticancer activity against breast cancer cells. Pharmaceutics. 2018;10(1):32. https:\/\/doi.org\/10.3390\/pharmaceutics10010032.","journal-title":"Pharmaceutics"},{"issue":"10","key":"1577_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3858\/emm.2009.41.10.080","volume":"41","author":"SJ Lim","year":"2009","unstructured":"Lim SJ, Choi MK, Kim MJ, Kim JK. \u03b1-Tocopheryl succinate potentiates the paclitaxel-induced apoptosis through enforced caspase 8 activation in human H460 lung cancer cells. Exp Mol Med. 2009;41(10):737\u201345. https:\/\/doi.org\/10.3858\/emm.2009.41.10.080.","journal-title":"Exp Mol Med"},{"issue":"7","key":"1577_CR25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3109\/03639045.2014.935390","volume":"41","author":"J Emami","year":"2015","unstructured":"Emami J, Rezazadeh M, Rostami M, et al. Co-delivery of paclitaxel and \u03b1-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy. Drug Dev Ind Pharm. 2015;41(7):1137\u201347. https:\/\/doi.org\/10.3109\/03639045.2014.935390.","journal-title":"Drug Dev Ind Pharm"},{"issue":"19","key":"1577_CR26","doi-asserted-by":"publisher","first-page":"9374","DOI":"10.1158\/0008-5472.CAN-06-2403","volume":"66","author":"T Hahn","year":"2006","unstructured":"Hahn T, Szabo L, Gold M, et al. Dietary administration of the proapoptotic vitamin E analogue \u03b1-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. Cancer Res. 2006;66(19):9374\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-2403.","journal-title":"Cancer Res"},{"key":"1577_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1054\/bjoc.2000.1559","volume":"84","author":"J Neuzil","year":"2001","unstructured":"Neuzil J, Weber T, Gellert N, et al. Selective cancer cell killing by \u03b1-tocopheryl succinate. Br J Cancer. 2001;84:87\u20139. https:\/\/doi.org\/10.1054\/bjoc.2000.1559.","journal-title":"Br J Cancer"},{"issue":"1","key":"1577_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12263-011-0242-x","volume":"7","author":"D Patacsil","year":"2012","unstructured":"Patacsil D, Osayi S, Tran AT, et al. Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cells. Genes Nutr. 2012;7(1):83\u20139. https:\/\/doi.org\/10.1007\/s12263-011-0242-x.","journal-title":"Genes Nutr"},{"issue":"2","key":"1577_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1208\/s12248-014-9705-5","volume":"17","author":"S Alqahtani","year":"2015","unstructured":"Alqahtani S, Kaddoumi A. Vitamin E transporters in cancer therapy. AAPS J. 2015;17(2):313\u201322. https:\/\/doi.org\/10.1208\/s12248-014-9705-5.","journal-title":"AAPS J"},{"issue":"10","key":"1577_CR30","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/sj.bjc.6601360","volume":"89","author":"J Neuzil","year":"2003","unstructured":"Neuzil J. Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br J Cancer. 2003;89(10):1822\u20136. https:\/\/doi.org\/10.1038\/sj.bjc.6601360.","journal-title":"Br J Cancer"},{"issue":"3","key":"1577_CR31","first-page":"863","volume":"8","author":"T Weber","year":"2002","unstructured":"Weber T, Lu M, Andela L, et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factorrelated apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res. 2002;8(3):863\u20139.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1577_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2011.04.001","volume":"307","author":"X Zhang","year":"2011","unstructured":"Zhang X, Peng X, Yu W, et al. Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux. Cancer Lett. 2011;307(2):174\u201381. https:\/\/doi.org\/10.1016\/j.canlet.2011.04.001.","journal-title":"Cancer Lett"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01577-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-021-01577-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01577-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:19:30Z","timestamp":1637021970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-021-01577-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,23]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s12032-021-01577-9","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,23]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest or competing interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Due to the fact that the study was no human or animal study, no ethical approval has been taken.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have agreed to publish this work in the current form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"144"}}